SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-018259
Filing Date
2023-06-23
Accepted
2023-06-23 16:07:33
Documents
13
Period of Report
2023-06-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20230614c_8k.htm   iXBRL 8-K 74337
  Complete submission text file 0001437749-23-018259.txt   207985

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA opk-20230622.xsd EX-101.SCH 3401
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20230622_def.xml EX-101.DEF 11421
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20230622_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20230622_pre.xml EX-101.PRE 11581
7 EXTRACTED XBRL INSTANCE DOCUMENT opk20230614c_8k_htm.xml XML 2566
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 231037729
SIC: 2834 Pharmaceutical Preparations